selected publications
-
academic article
- A capsaicinoid¿based soft drug, AG1529, for attenuating TRPV1¿mediated histaminergic and inflammatory sensory neuron excitability. SCIENTIFIC REPORTS. 246-256. 2021
- Phenylalanine-derived beta-Lactam TRPM8 modulators. Configuration effect on the antagonist activity. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2370-2392. 2021
- A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability. SCIENTIFIC REPORTS. 1-18. 2020
- Is TRPA1 Burning Down TRPV1 as Druggable Target for the Treatment of Chronic Pain?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 1-20. 2019
- Effect of a novel TRPV1 antagonist on capsaicin nociceptors. FRONTIERS IN CELLULAR NEUROSCIENCE. 1-4. 2018
- Targeting transient receptor potential vanilloid 1 channel (TRPV1) softly: the discovery of Passerini adducts as a topical treatment for inflammatory skin disorders. JOURNAL OF MEDICINAL CHEMISTRY. 4436-4455. 2018
-
congress communication
- 1(2-((4-Hydroxy-2-Iodo-5-Methoxybenzyl) Amino)-2-Oxoethyl Dodecanoate (AG1529) a Soft Capsaicinoid Reduces Capsaicin Receptor (TRPV1)-mediated Inflammatory and Histaminergic Nociceptor Excitability 2021
- Direct conversion of human fibroblasts to sensory neurons 2021
- Evaluación de los mecanismos moleculares que se establecen durante una crisis de migraña a nivel de SNP 2021
- Evaluación de los mecanismos moleculares que se establecen durante una crisis de migraña a nivel de SNP 2020
- Evaluación de los mecanismos moleculares que se establecen durante una crisis de migraña a nivel de SNP 2020
- In vitro characterization of a TRPV1 soft antagonist. 2019
- In vitro characterization of a TRPV1 soft antagonist. 2019
- A capsaicin-based TRPV1 soft antagonist as an anti-pruritic drug candidate 2019
- In vitro characterization of a TRPV1 soft antagonist. 2019
- Targeting TRPV1 softly: the discovery of Passerini adducts as a topical treatment for inflammatory skin disorders 2018